News

Interview with Stewart Cole

an interview with Stewart Cole
Dr. Stewart Cole

Stewart Cole helped create the Global Health Institute in 2007. Located at the Ecole polytechnique fédérale de Lausanne (EPFL), will use cutting-edge techniques to seek solutions to tuberculosis, a growing threat worldwide. Dr Cole’s work on tuberculosis, leprosy, AIDS, gas gangrene and bacterial molecular genetics is widely acclaimed throughout the world. He was a leading member of the team of scientists who determined the complete nucleotide sequence for the AIDS virus. He is also considered to be a pioneer in the genomics of tuberculosis and leprosy bacilli.

More News
23 Aug 2022
Last week, the PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings...
4 May 2022
Earlier this week, the World Health Organization (WHO) released a rapid communication which detailed the upcoming changes to the treatment guidance for drug-resistant tuberculosis (DR-TB). These guidelines are used to inform national TB programmes globally on how to treat patients with these...
5 Apr 2022
On April 01, 2022, the Stop TB Partnership launched the second online consultation for the new Global Plan to End TB 2023-2030. Over the years, the Global Plans have been important tools for advocacy and resource mobilization, and served as a reference document for donors and stakeholders. In May...